In einem RT-PCR Ansatz aus neuronalen post mortem Gewebe des Menschen konnten EPB41 (Erythrozytäres Protein Bande 4.1) Spleißformen in verschiedenen Hirnregionen nachgewiesen werden. In einem weiteren RT-PCR Ansatz wurden höhermolekulare p4.1R-Spleißormen generiert, kloniert und zwei der erhaltenen Spleißformen (Klon 9 und Klon 13) charakterisiert. In einer In-situ-Hybridisierungsstudie an humanen Temporalkortex und Hippocampus konnten EPB41-Isoformen in fast allen Neuronen nachgewiesen werden. In immunhistochemischen Untersuchungen mit selbstgenerierten p4.1R spezifischen Antikörper wurden ebenfalls ausschließlich Neurone markiert. In proteinbiochemischen Untersuchungen konnte in verschiedenen humanen Hirnareale mit den p4.1R spezifischen Antikörpern eine 110 kDa und 120 kDa immunreaktive Bande nachgewiesen werden. In Experimenten an Primärkulturen von Rattenneuronen konnte eine Herunterregulation der p4.1R Proteine sowie der mRNA von p4.1R durch Verarmung des funktionellen Pools an G-Proteinen der Rho-Familie in der Zelle gezeigt werden. Die GTPasen der Rho-Familie regulieren unter anderem die Plastizität des Dendritenbaumes von Neuronen. / In a RT-PCR approach using human postmortem cerebral tissue from different brain regions several EPB41 (erythrocyte protein band 4.1) spliceforms could be generated. The amplificates were cloned and two of the highmolecular EPB41 spliceforms Klon 9 and Klon 13 were characterized. Klon 9 is a new spliceform, Klon13 is identical with EPB41 (accesion number AF156225). In an in situ hybridization study the EPB41 spliceforms were detected in almost all neurons of the temporal cortex and the hippocampus. Immunhistochemical localization of the p4.1R immunreactive proteins in human temporal cortex using p4.1R specific peptide antibodies, confirmed these results. The stning pattern of soma and dendrites of the neurones was punctuated. In Western Blot experiments a 110 kDa and 120 kDa p4.1R immunreactive proteinband was detected. A regulation of the protein 4.1R immunreactive proteins as well as the mRNA of protein 4.1 was found in experiments in which the functional pool of Rho GTPases in hippocampal primary neurones of the rat was manipulated.

A via de sinalização da GTPase RhoA atua em diversos processos celulares. Para avaliar o comportamento de RhoA, após estresse causado por radiação ultravioleta, foram gerados clones mutantes que expressam RhoA em seu estado constitutivamente ativo e dominante negativo. Após exposição das linhagens à radiação ultravioleta, observou-se uma maior sensibilidade e um maior tempo de recuperação das linhagens quando a atividade de RhoA é reduzida. Estes prejuízos no reparo prejudicaram a proliferação e sobrevivência celular quando da deficiência na atividade de RhoA. Em linhagens deficientes na via de NER, percebemos que estas linhagens possuem uma capacidade ainda mais reduzida de reparo quando a atividade de RhoA é inibida. / The RhoA GTPase signaling pathway acts on many cellular processes. To evaluate this possible RhoA function after stress caused by ultraviolet radiation, mutant clones expressing RhoA in its constitutively active or dominant negative forms were generated. After exposure of the cells to ultraviolet radiation, cell lines showed a higher sensitivity and a delayed recovery capacity when the RhoA activity is reduced. The impaired repair reduced the cells proliferation and survival under RhoA deficiency. In cell lines deficient in NER pathway, we notice that these cell lines, have a further reduced ability to repair damaged DNA under RhoA inhibition.

L'exoenzyme S, une toxine de type III, de Pseudomonas aeruginosa possède un domaine GAP (GTPase Activating Protein) (ExoSGAP) inhibant les Rho GTPases (Rho, Rac, Cdc42) et la phagocytose dans les cellules de Mammifères en culture. J'ai utilisé une approche de transgenèse chez Drosophila melanogaster en utilisant un système d'expression tissu-spécifique inductible (UAS-Gal4) afin d'exprimer ExoSGAP. Nous avons montré qu'ExoSGAP cible in vivo les Rho GTPases Rho, Rac1, Rac2 et Cdc42. ExoSGAP affecte la résistance des mouches aux infections en inhibant la phagocytose des bactéries par les plasmatocytes, des cellules de type macrophage, mais n'a pas d'effet sur les voies NF-kB. Une approche génétique a permis d'identifier de nouvelles cibles de la toxine, en recherchant des gènes dont la dérégulation modifie le phénotype d'œil ou d'aile induit par l'expression d'ExoSGAP. Nous avons identifié plusieurs gènes pouvant avoir un rôle dans les voies des JNK et NF-kB Ces résultats valident une stratégie d'étude des toxines de type III par transgenèse chez la drosophile.J'ai parallèlement montré la spécificité de la GTPase Rac2 dans la résistance des mouches aux infections bactériennes. Rac2 participe notamment à la phagocytose.<br />Les travaux du Dr. H. Tricoire ont permis d'identifier 180 gènes dont la dérégulation modifie la réponse des mouches à un stress oxydant. J'ai testé 105 de ces lignées pour leur résistance aux infections, afin d'étudier une corrélation possible entre la réponse aux stress oxydant et infectieux. Ce crible a permis de montrer l'implication d'une protéine à domaine lectine PSLR (Pseudomonas Sensitive Lectin Receptor) dans la réponse immunitaire de la drosophile.

Spinal muscular atrophy (SMA) is the leading genetic cause of death of young children. It is an autosomal recessive disease caused by the mutation and/or the deletion within the ubiquitously expressed survival motor neuron 1 (SMN1) gene. SMA pathology is characterized by spinal cord motor neuron degeneration, neuromuscular junction (NMJ) defects and muscular atrophy. Upon disease onset, SMA patients progressively become paralyzed and in the most severe cases, they die due to respiratory complications. Over the years, it has become clear that SMN is a multi-functional protein with important roles in small nuclear ribonucleoprotein (snRNP) assembly, RNA metabolism, axonal outgrowth and pathfinding, mRNA transport as well as in the functional development of NMJs, skeletal muscle and cardiac muscle. However, it remains unclear which of these functions, and the respective perturbed molecular pathways, dictate SMA pathogenesis. Here, we have established Smn-depleted PC12 cells and an intermediate SMA mouse model to characterize a role for Smn in the regulation of actin cytoskeleton dynamics. We find that Smn depletion results in the increased expression of profilin IIa and active RhoA (RhoA-GTP) as well as the decreased expression of plastin 3 and Cdc42. Importantly, the inhibition of rho-kinase (ROCK), a direct downstream regulator of RhoA, significantly increased the lifespan of SMA mice and shows beneficial potential as a therapeutic strategy for SMA. In an addition, we have uncovered a muscle- and motor neuron-independent role for SMN in the regulation of pancreatic development and glucose metabolism in SMA mice and type 1 SMA patients. This finding highlights the importance of combining a glucose tolerance assessment of SMA patients with their existing clinical care management. Thus, our work has uncovered two novel and equally important roles for the SMN protein, both of which contribute significantly to SMA pathogenesis.

Spinal muscular atrophy (SMA) is the leading genetic cause of death of young children. It is an autosomal recessive disease caused by the mutation and/or the deletion within the ubiquitously expressed survival motor neuron 1 (SMN1) gene. SMA pathology is characterized by spinal cord motor neuron degeneration, neuromuscular junction (NMJ) defects and muscular atrophy. Upon disease onset, SMA patients progressively become paralyzed and in the most severe cases, they die due to respiratory complications. Over the years, it has become clear that SMN is a multi-functional protein with important roles in small nuclear ribonucleoprotein (snRNP) assembly, RNA metabolism, axonal outgrowth and pathfinding, mRNA transport as well as in the functional development of NMJs, skeletal muscle and cardiac muscle. However, it remains unclear which of these functions, and the respective perturbed molecular pathways, dictate SMA pathogenesis. Here, we have established Smn-depleted PC12 cells and an intermediate SMA mouse model to characterize a role for Smn in the regulation of actin cytoskeleton dynamics. We find that Smn depletion results in the increased expression of profilin IIa and active RhoA (RhoA-GTP) as well as the decreased expression of plastin 3 and Cdc42. Importantly, the inhibition of rho-kinase (ROCK), a direct downstream regulator of RhoA, significantly increased the lifespan of SMA mice and shows beneficial potential as a therapeutic strategy for SMA. In an addition, we have uncovered a muscle- and motor neuron-independent role for SMN in the regulation of pancreatic development and glucose metabolism in SMA mice and type 1 SMA patients. This finding highlights the importance of combining a glucose tolerance assessment of SMA patients with their existing clinical care management. Thus, our work has uncovered two novel and equally important roles for the SMN protein, both of which contribute significantly to SMA pathogenesis.

A via de sinalização da GTPase RhoA atua em diversos processos celulares. Para avaliar o comportamento de RhoA, após estresse causado por radiação ultravioleta, foram gerados clones mutantes que expressam RhoA em seu estado constitutivamente ativo e dominante negativo. Após exposição das linhagens à radiação ultravioleta, observou-se uma maior sensibilidade e um maior tempo de recuperação das linhagens quando a atividade de RhoA é reduzida. Estes prejuízos no reparo prejudicaram a proliferação e sobrevivência celular quando da deficiência na atividade de RhoA. Em linhagens deficientes na via de NER, percebemos que estas linhagens possuem uma capacidade ainda mais reduzida de reparo quando a atividade de RhoA é inibida. / The RhoA GTPase signaling pathway acts on many cellular processes. To evaluate this possible RhoA function after stress caused by ultraviolet radiation, mutant clones expressing RhoA in its constitutively active or dominant negative forms were generated. After exposure of the cells to ultraviolet radiation, cell lines showed a higher sensitivity and a delayed recovery capacity when the RhoA activity is reduced. The impaired repair reduced the cells proliferation and survival under RhoA deficiency. In cell lines deficient in NER pathway, we notice that these cell lines, have a further reduced ability to repair damaged DNA under RhoA inhibition.

Spinal muscular atrophy (SMA) is the leading genetic cause of death of young children. It is an autosomal recessive disease caused by the mutation and/or the deletion within the ubiquitously expressed survival motor neuron 1 (SMN1) gene. SMA pathology is characterized by spinal cord motor neuron degeneration, neuromuscular junction (NMJ) defects and muscular atrophy. Upon disease onset, SMA patients progressively become paralyzed and in the most severe cases, they die due to respiratory complications. Over the years, it has become clear that SMN is a multi-functional protein with important roles in small nuclear ribonucleoprotein (snRNP) assembly, RNA metabolism, axonal outgrowth and pathfinding, mRNA transport as well as in the functional development of NMJs, skeletal muscle and cardiac muscle. However, it remains unclear which of these functions, and the respective perturbed molecular pathways, dictate SMA pathogenesis. Here, we have established Smn-depleted PC12 cells and an intermediate SMA mouse model to characterize a role for Smn in the regulation of actin cytoskeleton dynamics. We find that Smn depletion results in the increased expression of profilin IIa and active RhoA (RhoA-GTP) as well as the decreased expression of plastin 3 and Cdc42. Importantly, the inhibition of rho-kinase (ROCK), a direct downstream regulator of RhoA, significantly increased the lifespan of SMA mice and shows beneficial potential as a therapeutic strategy for SMA. In an addition, we have uncovered a muscle- and motor neuron-independent role for SMN in the regulation of pancreatic development and glucose metabolism in SMA mice and type 1 SMA patients. This finding highlights the importance of combining a glucose tolerance assessment of SMA patients with their existing clinical care management. Thus, our work has uncovered two novel and equally important roles for the SMN protein, both of which contribute significantly to SMA pathogenesis.

Indiana University-Purdue University Indianapolis (IUPUI) / Recent preclinical reports have provided evidence that endothelial colony forming cells (ECFCs), a subset of endothelial progenitor cells, significantly improve vessel formation, largely due to their robust vasculogenic potential. While it has been known that the Rho family GTPase Cdc42 is involved in this ECFC-driven vessel formation process, the effect of extracellular matrix (ECM) stiffness on its activity during vessel formation is largely unknown. Using a fluorescence resonance energy transfer (FRET)-based Cdc42 biosensor, we examined the spatio-temporal activity of Cdc42 of ECFCs in three-dimensional (3D) collagen matrices with varying stiffness. The result revealed that ECFCs exhibited an increase in Cdc42 activity in a soft (150 Pa) matrix, while they were much less responsive in a rigid (1 kPa) matrix. In both soft and rigid matrices, Cdc42 was highly activated near vacuoles. However, its activity is higher in a soft matrix than that in a rigid matrix. The observed Cdc42 activity was closely associated with vacuole formation. Soft matrices induced higher Cdc42 activity and faster vacuole formation than rigid matrices. However, vacuole area is not dependent on the stiffness of matrices. Time courses of Cdc42 activity and vacuole formation data revealed that Cdc42 activity proceeds vacuole formation. Collectively, these results suggest that matrix stiffness is critical in regulating Cdc42 activity in ECFCs and its activation is an important step in early vacuole formation.

No description available.

No description available.